Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Hawkey

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Nutrition|June 23, 2007
Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosaAmy V Gasper, Maria Traka, James R Bacon, et al.
BMC Microbiology|February 6, 2009
Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytesKenneth H Mellits, Ian F Connerton, Michael F Loughlin, et al.
Scandinavian Journal of Gastroenterology|September 30, 2008
Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagusRajvinder Singh, Haris Karageorgiou, Victoria Owen, et al.
Journal of Clinical Pharmacology|June 24, 2003
Characterization of etoricoxib, a novel, selective COX-2 inhibitorAimee Dallob, Christopher J Hawkey, Howard Greenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated studyClare Atherton, John Jones, Brian McKaig, et al.
Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialThomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, et al.
The New England Journal of Medicine|February 24, 2006
Response to expression of concern regarding VIGOR studyClaire Bombardier, Loren Laine, Ruben Burgos-Vargas, et al.
The American Journal of Clinical Nutrition|December 8, 2005
Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoliAmy V Gasper, Ahmed Al-Janobi, Julie A Smith, et al.
Trials|February 15, 2022
Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)Diane J Stevenson, Anthony J Avery, Carol Coupland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2008
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazoleChristopher J Hawkey, Christian Ell, Bernd Simon, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Nutrition|June 23, 2007
Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosaAmy V Gasper, Maria Traka, James R Bacon, et al.
BMC Microbiology|February 6, 2009
Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytesKenneth H Mellits, Ian F Connerton, Michael F Loughlin, et al.
Scandinavian Journal of Gastroenterology|September 30, 2008
Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagusRajvinder Singh, Haris Karageorgiou, Victoria Owen, et al.
Journal of Clinical Pharmacology|June 24, 2003
Characterization of etoricoxib, a novel, selective COX-2 inhibitorAimee Dallob, Christopher J Hawkey, Howard Greenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated studyClare Atherton, John Jones, Brian McKaig, et al.
Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialThomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, et al.
The New England Journal of Medicine|February 24, 2006
Response to expression of concern regarding VIGOR studyClaire Bombardier, Loren Laine, Ruben Burgos-Vargas, et al.
The American Journal of Clinical Nutrition|December 8, 2005
Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoliAmy V Gasper, Ahmed Al-Janobi, Julie A Smith, et al.
Trials|February 15, 2022
Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)Diane J Stevenson, Anthony J Avery, Carol Coupland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2008
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazoleChristopher J Hawkey, Christian Ell, Bernd Simon, et al.
Pageof 5